GAABRYDA

WIPO WIPO 2021

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark GAABRYDA was filed as Word mark on 03/08/2021 at the World Intellectual Property Organization.

Trademark Details Last update: August 9, 2022

Trademark form Word mark
File reference 1587407
Countries Australia Canada Switzerland China European Community United Kingdom Japan South Korea Norway
Base trademark US No. 90232607, October 2, 2020
Application date March 8, 2021
Expiration date March 8, 2031

Trademark owner

100 Matsonford Road
5 Radnor Corporate Center, Suite 500
US

Trademark representatives

P.O. Box 1022 Minneapolis MN 55440-1022 US

goods and services

05 Pharmaceutical preparations for the treatment of seizures and epilepsy, status epilepticus, encephalopathies, neurodegenerative disease, cerebrovascular disease, movement disorders, traumatic brain injury and other neurologic conditions, substance abuse, substance withdrawal, dementia, delirium, schizophrenia, bipolar disorder, psychosis, depression, and other psychiatric conditions

Trademark history

Date Document number Area Entry
August 5, 2022 2022/32 Gaz CA Rejection
May 4, 2022 2022/19 Gaz KR Rejection
March 22, 2022 2022/12 Gaz CH Rejection
March 3, 2022 2022/9 Gaz NO Rejection
February 24, 2022 2022/8 Gaz JP Rejection
September 8, 2021 2021/36 Gaz EM Rejection
September 1, 2021 2021/35 Gaz GB Rejection
August 19, 2021 2021/33 Gaz CN Rejection
July 7, 2021 2021/27 Gaz AU Rejection
March 8, 2021 2021/14 Gaz US Registration

ID: 141587407